system. J. Neurochem . 110: 1661–1673. 2008 Drake, P.M. , Nathan. J.K., Stock, C.M., Chang, P.V., Muench, M.O., Nakata, D., Reader, J.R., Gip, P., Golden, K.P., Weinhold, B. , Gerardy-Schahn, R. , Troy, F.A [...] consequences of status epilepticus. Neuroreport . 21 (8):549-53. 2009 Drake, P. M , Stock, C. M, Nathan, J. K, Gip, P., Golden, K. P., Weinhold, B., Gerardy-Schahn, R. , and Bertozzi, C.R. (2009) Polysialic [...] (Sialoglycobiology in mammalian development) 2022 Linder AT , Schmidt M, Hitschfel J, Abeln M , Schneider P, Gerardy-Schahn R , Münster-Kühnel AK , Nitschke L (2022). Sialic acids on B cells are crucial for their

humoral rejection in a stable renal allograft. Transplantation 2003; 76(7): 1132-3 [case report] Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, Kreipe H: Donor origin of de-novo [...] Hematol 2003; 82: 605-11 Lichtinghagen R, Bahr MJ, Wehmeier N, Michels, D Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH: Expression and coordinated regulation of matrix metalloproteinases in chronic [...] print] Matussek A, Lauber J, Bergau A, Hansen W, Rohde M, Dittmar KE, Gunzer M, Mengel M, Gatzlaff P, Hartmann M, Buer J, Gunzer F: Molecular and functional analysis of Shiga toxin induced response patterns

Ravichandra A, Huebener P, Anke H, Shi H, Martínez García de la Torre RA, Smith JR, Henderson NC, Vondran FWR, Rothlin CV, Baehre H , Tabas I, Sancho-Bru P, Schwabe RF. The purinergic P2Y14 receptor links [...] Steinchen W, Nuss AM, Beckstette M, Hantke I, Driller K, Sudzinová P, Krásný L, Kaever V , Dersch P, Bange G, Wilson DN, Turgay K. The alarmones (p)ppGpp are part of the heat shock response of Bacillus subtilis [...] 2023 Covaleda-Cortés G, Mechaly A, Brissac T, Baehre H , Devaux L, England P, Raynal B, Hoos S, Gominet M, Firon A, Trieu-Cuot P, Kaminski PA. The c-di-AMP-binding protein CbpB modulates the level of ppGpp

(Hazard Ratio 0,45, 95% CI: 0,38 - 0,54; p<0,00001) als auch beim Gesamtüberleben (OS) mit 31,5 Monaten gegenüber 16,1 Monaten (Hazard Ratio 0,47, 95% CI: 0,38-0,58; p<0,00001). Das Risiko zu versterben wurde [...] HR 0,69, 95% CI 0,55 - 0,87, p=0,001). Allerdings zeigte sich kein signifikanter Unterschied für das Gesamtüberleben (OS, 50,9 vs. 55,8 Monate, HR 0,98, 95% CI 0,76 - 1,26, p=0,884). Bemerkenswert ist hier [...] (Hazard Ratio 0,45, 95% CI: 0,38 - 0,54; p<0,00001), als auch für das Gesamtüberleben (OS) mit 31,5 Monaten versus 16,1 Monaten (Hazard Ratio 0,47, 95%CI: 0,38-0,58; p<0.00001). Das Risiko zu versterben wurde

1394040. doi: 10.3389/fphys.2024.1394040 Reindl T., Giese S., Greve J.N., Reinke P.Y., Chizhov I., Latham S.L., Mulvihill D.P., Taft M.H., Manstein D.J. (2022) Distinct actin-tropomyosin cofilament populations [...] quantum dot triexciton imaging. FEBS Open Bio. doi:10.1002/2211-5463.13246 Rai, A., Klare, J.P., Reinke, P.Y.A, Englmaier, F., Fohrer, J., Fedorov, R., Taft, M.H. Chizhov, I., Curth,U., Plettenburg, O [...] , Kremneva, E., Reindl, T., Kotila, T., Kogan, K., Gressin, l., Gunning, P.W., Manstein, D.J., Michelot, A., and Lappalainen, P. (2017) Tropomyosin isoforms specify functionally distinct actin filament

Bachelor of Science Biochemistry Molecular Biochemistry and Methods (BCB P 15) Master of Science Biochemistry Biophysical Chemistry (BCM P 04), organization of module Human Medicine and Dentistry Biochemist

Urologe A 2011; 50(2): 205-7 [German] Focken T, Steinemann D, Skawran B, Hofmann W, Ahrens P , Arnold N, Kroll P, Kreipe H , Schlegelberger B, Gadzicki D: Human BRCA1-associated breast cancer: no increase [...] trials in German-speaking pathology.] Pathologe 2011 ; 32(5): 357-9 [German] Kümpers P, Gueler F, David S, Van Slyke P, Dumont DJ, Park JK, Bockmeyer CL , Parikh SM, Pavenstädt H, Haller H, Sushakova N: [...] specific antibody. PLoS One 2011; 6(1): e15921 Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J , Kreipe H , Devière J, Manns

PMC10719480. Van Loon E, Lamarthée B, Callemeyn J, Farhat I, Koshy P, Anglicheau D, Cippà P, Franken A, Gwinner W , Kuypers D, Marquet P, Rinaldi A, Tinel C, Van Brussel T, Van Craenenbroeck A, Varin A, [...] Lamarthée B, Antoranz A, Debyser T, Koshy P, Anglicheau D, Colpaert J, Gwinner W , Halloran PF, Kuypers D, Tinel C, Van Craenenbroeck A, Van Loon E, Marquet P, Bosisio F, Naesens M. The Clinical Relevance [...] 32113272 Labriffe M, Woillard JB, Gwinner W , Braesen JH, Anglicheau D, Rabant M, Koshy P, Naesens M, Marquet P. Machine learning-supported interpretations of kidney graft elementary lesions in combination

Biochemistry Lecture „Biophysikalische Chemie“ (1.semester, Module BCM P 04) Practical course „Biophysikalische Chemie“ (1. semester, Modul BCM P 04) Lab internships and Master thesis (scheduled individually)

Vogt, P. M., & Bucan, V. (2017). Anti-apoptotic protein Lifeguard does not act as a tumor marker in breast cancer. Oncology Letters , 13 (3), 1518-1524. Müller, J., Maurer, V., Reimers, K., Vogt, P. M., [...] Reimers, K., Vogt, P. M., & Bucan, V. (2014). Role of lifeguard β-isoform in the development of breast cancer. Oncology reports , 32 (4), 1335-1340. Bucan, V., Choi, C. Y., Lazaridis, A., Vogt, P. M., & Reimers [...] activation. Oncology letters , 2 (3), 419-422. Bucan, V., Reimers, K., Choi, C. Y., Eddy, M. T., & Vogt, P. M. (2010). The anti-apoptotic protein lifeguard is expressed in breast cancer cells and tissues. Cellular